Literature DB >> 15506833

Cognitive strengths and weaknesses in children and adolescents homozygous for the galactosemia Q188R mutation: a descriptive study.

Kevin M Antshel1, Ingrid O Epstein, Susan E Waisbren.   

Abstract

Children and adolescents (n = 25) with galactosemia homozygous for the common Q188R mutation (substitution of glutamine codon 188 with arginine) were group matched for sex and age with healthy control participants (n = 20). Participants were administered an abbreviated neuropsychological battery by a doctoral-level psychologist. Results indicate that children and adolescents with galactosemia function generally within the low average IQ range, with a small standard deviation (indicating a relatively homogeneous IQ profile), and have many features suggestive of left-hemisphere dysfunction. Word retrieval difficulties are a primary component of the galactosemia profile. In addition, participants with galactosemia have less well-developed executive functions. Child and parental reports of behavioral symptoms differ; parents reported that their children had more internalizing symptoms than the children with galactosemia self-reported. Cognitive complications in galactosemia appear to emerge even in well-treated children.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15506833     DOI: 10.1037/0894-4105.18.4.658

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  32 in total

1.  Structure-activity analysis and cell-based optimization of human galactokinase inhibitors.

Authors:  Si Odejinmi; Rg Rascon; M Tang; H Vankayalapati; K Lai
Journal:  ACS Med Chem Lett       Date:  2011-09-08       Impact factor: 4.345

2.  The neuropsychological profile of galactosaemia.

Authors:  Claire M Doyle; Shelley Channon; Danuta Orlowska; Philip J Lee
Journal:  J Inherit Metab Dis       Date:  2010-07-06       Impact factor: 4.982

Review 3.  Innovative therapy for Classic Galactosemia - tale of two HTS.

Authors:  M Tang; S I Odejinmi; H Vankayalapati; K J Wierenga; K Lai
Journal:  Mol Genet Metab       Date:  2011-10-01       Impact factor: 4.797

4.  Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment.

Authors:  K P Coss; P P Doran; C Owoeye; M B Codd; N Hamid; P D Mayne; E Crushell; I Knerr; A A Monavari; E P Treacy
Journal:  J Inherit Metab Dis       Date:  2012-07-03       Impact factor: 4.982

5.  Differential phonological awareness skills in children with classic galactosemia: a descriptive study of four cases.

Authors:  Fiona M Lewis; David J Coman; Maryann Syrmis; Sarah Kilcoyne; Bruce E Murdoch
Journal:  JIMD Rep       Date:  2012-12-29

6.  Cross-sectional analysis of speech and cognitive performance in 32 patients with classic galactosemia.

Authors:  Björn Hoffmann; Udo Wendel; Susanne Schweitzer-Krantz
Journal:  J Inherit Metab Dis       Date:  2011-02-24       Impact factor: 4.982

7.  Developmental Outcomes of School-Age Children with Duarte Galactosemia: A Pilot Study.

Authors:  Mary Ellen Lynch; Nancy L Potter; Claire D Coles; Judith L Fridovich-Keil
Journal:  JIMD Rep       Date:  2015-02-15

8.  Distinct roles of galactose-1P in galactose-mediated growth arrest of yeast deficient in galactose-1P uridylyltransferase (GALT) and UDP-galactose 4'-epimerase (GALE).

Authors:  Jane Odhiambo Mumma; Juliet S Chhay; Kerry L Ross; Jana S Eaton; Karen A Newell-Litwa; Judith L Fridovich-Keil
Journal:  Mol Genet Metab       Date:  2007-11-05       Impact factor: 4.797

9.  Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT) - deficient mouse model.

Authors:  Manshu Tang; Anwer Siddiqi; Benjamin Witt; Tatiana Yuzyuk; Britt Johnson; Nisa Fraser; Wyman Chen; Rafael Rascon; Xue Yin; Harish Goli; Olaf A Bodamer; Kent Lai
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

10.  Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia.

Authors:  Emily L Ryan; Mary Ellen Lynch; Elles Taddeo; Tyler J Gleason; Michael P Epstein; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2013-01-15       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.